Learn how to identify compounded/counterfeit tirzepatide and its potential risks.
![Men onstage playing jazz music](/assets/images/dtc/0.0_Hero_Image-Desktop.jpg)
FOR ADULTS WITH TYPE 2 DIABETES
Mounjaro is proven to
help lower A1C*
*Along with diet and exercise
Mounjaro is proven to lower A1C in adults with type 2 diabetes*
*Along with diet and exercise.
What is Mounjaro?
Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus.
It is not known if Mounjaro can be used in people who have had pancreatitis. Mounjaro is not for use in people with type 1 diabetes. It is not known if Mounjaro is safe and effective for use in children under 18 years of age.
*In studies with or without diabetes medications, 75% to 90% of people taking Mounjaro reached an A1C of less than 7%, with an average starting A1C of 7.9% to 8.6% across the 5-mg, 10-mg, and 15-mg doses.
†Study results were measured at 40 and 52 weeks.
Select Safety Information
Warning:
Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Mounjaro and medicines that work like Mounjaro caused thyroid tumors, including thyroid cancer. It is not known if Mounjaro will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not take Mounjaro if you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Mounjaro is not a weight loss drug.
‡Individual results may vary. In studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5 mg) to 25 lb (15 mg).
Select Safety Information
Do not use Mounjaro if you or any of your family have ever had a type of thyroid cancer called MTC or if you have an endocrine system condition called MEN 2, or if you have had a serious allergic reaction to tirzepatide or any of the ingredients in Mounjaro.
![Man smiling into camera](/assets/images/dtc/ld-banner-care.png)
Getting the care you need can be quick and accessible
Explore speed, convenience, and access to focused care with independent telehealth or in-person providers through LillyDirect.
![Men onstage playing jazz music](/assets/images/dtc/home_cta.jpg)
Mounjaro Savings
We want to help. You may pay as little as $25 for a 1-month or 3-month prescription with the Mounjaro Savings Card.* †
*For eligible commercially insured patients with Mounjaro coverage. Governmental beneficiaries excluded, terms and conditions apply.
†One month is defined as 28 days and 4 pens. Three months is defined as 84 days and up to 12 pens.
LEARN MORESubject to Lilly USA, LLC's (Lilly's) right to terminate, rescind, revoke or amend the Mounjaro Savings Card Program (“Card” or “Program”) eligibility criteria and/or Card terms and conditions which may occur at Lilly's sole discretion, without notice, and for any reason, the Card expires and savings end on 12/31/2024. Card savings are not available to patients without commercial drug insurance or who are enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE®CHAMPUS, or any state prescription drug assistance program.
MONTHLY AND ANNUAL MAXIMUM SAVINGS: For patients with commercial insurance coverage for Mounjaro: You must have commercial insurance that covers Mounjaro®(tirzepatide) and a prescription consistent with FDA-approved product labeling to pay as little as $25 for a 1-month, 2-month, or 3-month prescription fill of Mounjaro. Month is defined as 28-days and up to 4 pens. Card savings are subject to a maximum monthly savings of up to $150 per 1-month prescription, $300 per 2-month prescription, or $450 per 3-month prescription fill and separate maximum annual savings of up to $1800 per calendar year. Card may be used for a maximum of up to 13 prescription fills per calendar year. Subject to Lilly USA, LLC's (“Lilly”) right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly's sole discretion, without notice, and for any reason, Card expires and savings end on 12/31/2024.
For patients with commercial insurance who do not have coverage for Mounjaro: You must have commercial insurance that does not cover Mounjaro and a prescription consistent with FDA-approved product labeling to obtain savings of up to $473 off your 1-month prescription fill of Mounjaro. Month is defined as 28-days and up to 4 pens. Card savings are subject to a maximum monthly savings of up to $473 and a separate maximum annual savings of up to $2,365 per calendar year. Card may be used for a maximum of up to 5 prescription fills per calendar year. Subject to Lilly’s right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason, Card expires and savings end on 12/31/2024.
ADDITIONAL TERMS AND CONDITIONS:
You are responsible for any applicable taxes, fees and any amount that exceeds the monthly or annual maximum benefits. Savings card activation
is required. This Card may be terminated, rescinded, revoked, or amended by Lilly at any time without notice and for any reason. Subject
to additional terms and conditions. Eligibility criteria and terms and conditions for the Mounjaro Savings Card Program may change from time
to time at Lilly's sole discretion and for any reason; the most current version can be found at
https://www.mounjaro.lilly.com/savings-resources#savings.
Card benefits void where prohibited by law.